AzTrials
AzTrials

Psychological DistressNCT06548282

Efficacy of Acceptance and Commitment Therapy for the Management of Quality of Life in Patients Post Myocardial Infarction

A study testing Acceptance and commitment therapy in people with Psychological Distress and Type D Personality, run by Fatima Jinnah Women University at 2 sites in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The present study aims to investigate the efficacy of acceptance and commitment therapy for the management of quality of life in patients post-myocardial infarction Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Acceptance and commitment therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesPakistan
Study dates
21 Jun 2024to 21 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • First-time diagnosed, non-hospitalized patients with myocardial infarction (MI).
  • Patients attending follow-up visits at the hospital.
  • Patients experiencing distress.
  • Patients exhibiting features of Type D personality.
  • Patients reporting low levels of:
  • Quality of Life (QoL)
Show all 14Show fewer
  • Medication adherence
  • Social support
  • Acceptance
  • Psychological flexibility
  • Patients aged 18 years and above.
  • Both genders.
  • Patients who can understand Urdu.
  • Patients who can provide informed consent.

Who cannot join

  • Hospitalized patients with myocardial infarction (MI).
  • Patients with myocardial infarction (MI) and other chronic co-morbid diseases, such as:
  • Cancer
  • Cognitive deficits
  • Chronic psychological disorders
  • Patients with silent myocardial infarction.
  • Patients younger than 18 years.

Trial locations and contacts

2 sites in 1 country.

Pakistan2 sites
  • Armed Forces Institute of Cardiology

    Rawalpindi, Punjab Province, 46000

  • Rawalpindi Institute of Cardiology

    Rawalpindi, Punjab Province, 46000

Other trials in Pakistan

About this study

The present study aims to investigate the efficacy of acceptance and commitment therapy for the management of quality of life in patients post-myocardial infarction

Read the detailed description

The current quantitative study is carried out in two steps. A cross-sectional survey assesses quality of life and associated factors during the first step. A randomized controlled trial will be done during the second step where patients with myocardial infarction who are identified with type D personality characteristics, psychological distress, low level of medication adherence, low social support, low quality of life, low acceptance and psychological flexibility will be randomly assigned to two groups i.e. waitlist control group and intervention group. The acceptance and commitment therapy would be implemented on participants in the interventional group. As the control group is the waitlist control group; initially no intervention will be given to participants in the control group but the intervention will be given to the control group participants once the study is completed.

Being tested
Acceptance and commitment therapy
Medical subject headings
Medication Adherence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acceptance and commitment therapyOther

    Introduction: Build rapport and complete pre-assessment questionnaires.

    First Session:

    Introduce therapist, ACT principles, and MI complications. Provide psychoeducation and assign homework.

    Second Session:

    Review feedback and encourage change. Assign homework.

    Third Session:

    Discuss acceptance and coping strategies. Assign homework.

    Fourth Session:

    Discuss cognitive diffusion and unhelpful thoughts. Assign homework.

    Fifth Session:

    Explore self-concept and mindfulness. Assign homework.

    Sixth Session:

    Identify and elaborate on values. Assign homework.

    Seventh Session:

    Discuss values, goals, and barriers. Assign homework.

    Eighth Session:

    Discuss commitment to action and relapse prevention. Administer post-test and express gratitude.

Study groups in NCT06548282
Study groupRoleWhat they receive
ExperimentalExperimentalWho receives intervention i.e. Acceptance and Commitment Therapy
Receives: Other: Acceptance and commitment therapy
Waitlist ControlActive comparatorWho would receive intervention after study completion
Receives: Other: Acceptance and commitment therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. World Health Organization Quality of Life Scale Urdu Version

    It has 26 items and four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items); it also contains quality of life and general health items. The minimum value is 26 and the maximum value is 130. Higher scores on the scale indicate higher quality of life and low scores indicate low quality of life.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2024
  2. Study start21 Jun 2024
  3. Primary completion21 Sep 2024
  4. Study completion21 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06548282
Sponsor's protocol ID
FJWU/EC/2024/88
Status last verified
Mar 2025
First submitted
7 Aug 2024
Last updated
4 Mar 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Acceptance and commitment therapy in people with Psychological Distress and Type D Personality, run by Fatima Jinnah Women University at 2 sites in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

World Health Organization Quality of Life Scale Urdu Version (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in